Ultrasound Innovation in Fertility-Sparing Treatment

On 23–24 January 2025, idsMED, through its Ultrasound Team led by Rex, participated in the 14th ASPIRE Masterclass: Fertility-Sparing Management for Adenomyosis. The event served as a key platform for knowledge exchange and clinical advancement, bringing together approximately 500 practitioners and doctors specialising in ultrasound.

During the masterclass, idsMED showcased the HIFU JC200 system, a newly introduced technology designed to support fertility-sparing treatment approaches. The system generated strong interest among attendees due to its non-invasive treatment capability, high-precision targeting, and potential to effectively manage adenomyosis while preserving uterine integrity. Its advanced imaging guidance and focused ultrasound energy enable accurate lesion ablation with minimal impact on surrounding tissues, supporting patient safety, reduced recovery time, and improved clinical outcomes.

The introduction of the HIFU JC200 offered added value to medical professionals by presenting a modern alternative to conventional surgical interventions, aligning with the growing demand for minimally invasive and fertility-preserving treatment options. Participation in this masterclass further reinforced idsMED’s commitment to advancing ultrasound innovation, supporting clinical excellence, and equipping healthcare professionals with advanced solutions to enhance patient care.